Spinout from Lexington's Agenus raises $40M in IPO
October 15, 2021 at 14:36 PM EDT
While MiNK Therapeutics Inc. is incorporated in New York City, half of employees and its main operations will be primarily based in Lexington, according to a company spokeswoman.
